Article Text

Download PDFPDF
THU0082 Clinical Characteristics of Nonradiographic Axial Spondyloarthritis in Korea: in Comparison with Ankylosing Spondylitis
  1. H. Jeong1,
  2. I.Y. Kim1,
  3. J. Hwang1,
  4. H. Kim1,
  5. C.H. Jeon2,
  6. J. Lee1,
  7. E.-M. Koh1,
  8. H.-S. Cha1
  1. 1Samsung Medical Center
  2. 2SoonChunHyang Hospital, Seoul, Korea, Republic Of

Abstract

Background There has been considerable research into clinical characteristics of nr-axSpA in western European or American population, but no data about Asian population.

Objectives To evaluate the clinical characteristics and outcomes of nonradiographic axial spondyloarthritis (nr-axSpA) in Korean patients.

Methods A retrospective analysis was performed of 155 patients with nr-axSpA at a single tertiary hospital between January 2001 and January 2011. Baseline characteristics and clinical courses of nr-axSpA were reviewed and compared with the ankylosing spondylitis (AS).

Results Fifty-two (33.5%) patients were female and mean disease duration was 61.4±46.1 months. In female, age at disease onset was older (33.4±11.4 vs 27.5±9.9 years, p=0.001) than male. When compared with AS, the mean age at symptom onset (29.5±10.8 vs 25.9±9.2, p<0.001) was older and male to female ratio (2:1 vs 5:1, p=0.001) was lower in patients with nr-axSpA. Among nr-axSpA, 29 (18.7%) patients progressed to AS during the follow-up period. The proportion of female was lower (14.3 vs 38.1%, p=0.015) and disease duration was significantly longer (106.1±37.1 vs 51.2±41.8 months, p<0.001) in patients with progressors than those of non-progressors. Minimal X-ray change at baseline was frequently found in progressors (69.0 vs 42.1%, p=0.009). Presence of syndesmophyte at baseline was a predictor for disease progression (HR 1.01, 95% CI 1.00-1.02, p=0.046).

Conclusions The male predominance is more prominent in Korean patients with SpA compared with Caucasians. Female nr-axSpA patients had late symptom onset and less progression to AS. Bony change at baseline was associated with disease progression.

Disclosure of Interest : None declared

DOI 10.1136/annrheumdis-2014-eular.3463

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.